| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print April 13, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratories of Retinal Cell Biology* and Vascular Biology and Metabolism,¶ and the Departments of Ophthalmology and Physiology, Keio University School of Medicine, Tokyo; and Chugai Pharmaceutical Company Limited, Tokyo, Japan
Interleukin (IL)-6, a potent proinflammatory cytokine, is suggested to be a risk factor for choroidal neovascularization (CNV) because of its increased levels in the serum of patients with age-related macular degeneration; however, the role of IL-6 in CNV has not been defined. The present study reveals the critical contribution of IL-6 signaling and its downstream STAT3 pathway to the murine model of laser-induced CNV. CNV induction by laser treatment stimulated IL-6 expression in the retinal pigment epithelium-choroid complex, and antibody-based blockade of IL-6 receptor or genetic ablation of IL-6 led to significant suppression of CNV. CNV generation was accompanied by STAT3 activation in choroidal endothelial cells and macrophages, and IL-6 receptor blockade resulted in selectively inhibited phosphorylation of STAT3 but not extracellular signal-regulated kinase 1/2. Consistently, pharmacological blockade of STAT3 pathway also suppressed CNV. In addition, IL-6 receptor neutralization led to significant inhibition of the in vivo and in vitro expression of inflammation-related molecules including monocyte chemotactic protein, intercellular adhesion molecule-1, and vascular endothelial growth factor, and of macrophage infiltration into CNV. These results indicate the significant involvement of IL-6 receptor-mediated activation of STAT3 inflammatory pathway in CNV generation, suggesting the possibility of IL-6 receptor blockade as a therapeutic strategy to suppress CNV associated with age-related macular degeneration.
This article has been cited by other articles:
 |
|
 |
|
  G. Shi, A. Maminishkis, T. Banzon, S. Jalickee, R. Li, J. Hammer, and S. S. Miller Control of Chemokine Gradients by the Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4620 - 4630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Chong, C. S. Boehlke, Q.-D. Zheng, L. Zhang, Y. Han, and D. N. Zacks Interleukin-6 as a Photoreceptor Neuroprotectant in an Experimental Model of Retinal Detachment Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3193 - 3200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, S. Ohno, Y. Oike, and S. Ishida Inhibition of Choroidal Neovascularization with an Anti-Inflammatory Carotenoid Astaxanthin Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1679 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2555 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al. Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
